MedTrace Logo

Evaluation of the Tantalus System in Type 2 Diabetic Subjects

NCT00276471 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2012-02-02

No results posted yet for this study

Summary

Metacure MC PT TAN2005-013 feasibility study is a prospective, multi-center, study to evaluate the safety and functionality of the TANTALUS System, in the treatment of obese T2DM patients, and to assess the effect of GCT ( Glycemic Control Treatment )on weight loss and glycemic control.

Conditions

Interventions

DEVICE

Implantable pulse generator and electrodes

Sponsors & Collaborators

  • MetaCure Limited

    lead INDUSTRY

Principal Investigators

  • Bernhard Ludvik, Prof. · Allgemeinen Krankenhauses der Stadt Wein AkH

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-31
Primary Completion
2007-01-31
Completion
2007-06-30

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00276471 on ClinicalTrials.gov